Montenegro vs Mus: HIV-positive TB patients on ART (antiretroviral therapy)
Montenegro
100.0%
in 2023
Mus
100.0%
in 2024
Montenegro rank
1st
Mus rank
1st
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Montenegro
- Mus
How they compare
Montenegro currently reports 100.0% against 100.0% in Mus, a difference of 0.0%.
The two have swapped places 1 time across 6 shared years of data; in 2006 it was Montenegro ahead.
Montenegro ranks 1st and Mus ranks 1st of 144 countries.
Across the 3 decades both report, Montenegro averaged higher in 2 and Mus in 1.
Head to head by decade
| Decade | Montenegro | Mus | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 100.0% | 80.0% | 20.0% | Montenegro |
| 2010s | 100.0% | 91.7% | 8.3% | Montenegro |
| 2020s | 75.0% | 100.0% | 25.0% | Mus |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Montenegro or Mus?
- Montenegro, at 100.0% against 100.0% in Mus as of 2023.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Montenegro and Mus?
- 0.0%, with Montenegro ahead.
- How many years of comparable data are there for Montenegro and Mus?
- 6 years are reported by both, from 2006 to 2023.
- How do Montenegro and Mus rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Montenegro ranks 1st and Mus ranks 1st of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.